| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.10▲ | 3.12▲ | 3.15▼ | 3.46▼ | 3.54▼ |
| MA10 | 3.10▲ | 3.17▼ | 3.24▼ | 3.53▼ | 3.63▼ |
| MA20 | 3.10▲ | 3.25▼ | 3.39▼ | 3.73▼ | 3.73▼ |
| MA50 | 3.16▼ | 3.47▼ | 3.52▼ | 3.78▼ | 3.55▼ |
| MA100 | 3.24▼ | 3.54▼ | 3.61▼ | 3.79▼ | 3.71▼ |
| MA200 | 3.37▼ | 3.66▼ | 3.78▼ | 3.99▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.008▲ | -0.006▼ | -0.027▼ | -0.055▼ | -0.086▼ |
| RSI | 58.807▲ | 32.487▼ | 30.072▼ | 35.081▼ | 43.633▼ |
| STOCH | 64.167 | 10.990▼ | 7.491▼ | 27.899 | 36.947 |
| WILL %R | -5.263▲ | -75.000▼ | -83.784▼ | -89.906▼ | -93.624▼ |
| CCI | 265.517▲ | -79.976 | -118.365▼ | -254.344▼ | -113.175▼ |
|
Sunday, March 08, 2026 05:57 AM
Prime Medicine Inc. (NASDAQ:PRME) is one of the best new penny stocks to buy. On March 3, Prime Medicine reported its full-year 2025 financial results, highlighting a shift toward its in vivo liver ...
|
|
Tuesday, March 03, 2026 10:22 AM
Prime Medicine (PRME) lost ~7% on Tuesday after the gene therapy developer reported its Q4 2025 results and highlighted its upcoming milestones, including plans to seek FDA nod for a treatment ...
|
|
Tuesday, March 03, 2026 05:31 AM
On track to file IND and/or CTA for Wilson Disease and AATD programs in 1H 2026 and mid-2026, respectively; initial clinical data for both expected in 2027 -- -- Ongoing engagement with FDA for PM359 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/03/26 | 3.37 | 3.42 | 3.04 | 3.15 | 3,919,462 |
| 27/03/26 | 3.57 | 3.64 | 3.29 | 3.38 | 4,075,850 |
| 26/03/26 | 3.56 | 3.835 | 3.56 | 3.64 | 1,807,664 |
| 25/03/26 | 3.59 | 3.75 | 3.585 | 3.63 | 2,257,562 |
| 24/03/26 | 3.51 | 3.5764 | 3.43 | 3.52 | 2,192,587 |
| 23/03/26 | 3.59 | 3.72 | 3.52 | 3.58 | 2,073,558 |
| 20/03/26 | 3.69 | 3.77 | 3.52 | 3.52 | 6,010,449 |
| 19/03/26 | 3.46 | 3.76 | 3.45 | 3.68 | 2,253,298 |
| 18/03/26 | 3.65 | 3.72 | 3.53 | 3.53 | 2,322,630 |
| 17/03/26 | 3.63 | 3.755 | 3.63 | 3.71 | 1,407,972 |
|
|
||||
|
|
||||
|
|